Skip to main navigation
Krystal Biotech, Inc.
  • Contact Us
  • Careers
  • Company
    • Leadership
    • Board of Directors
  • Science
    • Technology
    • Pipeline
    • Manufacturing
    • Therapeutic Areas
    • Medical Professionals
  • Product
    • Vyjuvek
  • Patients
    • Patient Resources
  • Investors
  • Contact Us

Investors

Investor Relations
  • Overview
  • News Releases
  • Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Scientific Publications
  • Email Alerts
  • Analyst Coverage
  • Investor FAQs

SEC Filing Details

Document Details

Form
DEF 14A
Filing Date
Apr 3, 2026
Document Date
Apr 3, 2026
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Krystal Biotech, Inc.
Issuer
Krystal Biotech, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Krystal Biotech, Inc.
Quick Links
  • Company
  • Science
  • Product
  • Patients
  • Investors
  • Contact Us
  • Careers

Contact Us

Krystal Biotech, Inc.

2100 Wharton St. Suite #701

Pittsburgh, PA 15203

reception is in Suite #310

412-586-5830

inquiries@krystalbio.com
X X

KRYSTAL®, VYJUVEK®, and their associated logos are trademarks owned by Krystal Biotech, Inc. All other trademarks are property of their respective owners.

© Krystal Biotech, Inc. 2023-2026 All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Compliance Program